Medivolve Inc MEDVF

Few notes I found from Marvel Diagnostics

[Sarb99]

Business Model
 
The non-invasive low-cost BlowFISH is a disruptive technology in an essential and fast growing market. The BlowFISH POC system comprises a standalone BlowFISH collector which, when coupled with our proposed FISH detection system it will have very high sensitivity (potentially: 100%), excellent specificity (up to 100% when coupled with FISH), a short single test run time and high capacity (10 min/test, 180/hr capacity). The technology will be rolled out sequentially. The stand-alone collector (BlowFISH) will come to market first as a direct replacement for the nasopharyngeal swab. When the FISH detection system is fully-developed the standalone BlowFISH POC will be sold directly to customers while the detection equipment will be loaned with a multi-year contract and minimum number of kits purchase agreement.
 
Customers

Mass screening will be required to safely operate many entities including government agencies, hospitals, schools, and entertainment venues. In addition, many businesses that require one-to-one interaction, such as medical and dental offices, will be potential customers that would highly benefit from BlowFISH or BlowFISH POC. Children and adults, particularly those who require multiple sampling, are also potential customers.
 
Sales & Marketing Strategy
 
We have an existing Partnership with UCLA Health with plans for expansion with UC Health and other potential potential partnerships. In addition, we have local non-profit groups that would like to use our system for the testing of underrepresented and low-income communities. We have already been contacted by many business entities to develop partnership as they recognized the value of BlowFISH on their products.